#United States #New York #Investment #Black Pearl #Selectis Health

Black Pearl Equities Launches Tender Offer for Selectis Health

In a significant move within the healthcare investment landscape, Black Pearl Equities, a New York-based investment group, has officially initiated a tender offer to purchase all outstanding shares of Selectis Health, Inc. The acquisition price is set at $5.75 per share in cash, a strategic decision aimed at consolidating Black Pearl's presence in the healthcare sector.

This tender offer is part of a broader merger agreement established on June 22, 2026, between Black Pearl and Selectis. The completion of this transaction is contingent upon several key conditions, including the necessary shareholder approvals and regulatory clearances, as outlined in the recently released press statement.

The tender offer is scheduled to expire on August 10, 2026, at 5:00 PM (New York City time), unless an extension is announced. The transaction requires that at least 70% of the outstanding shares of Selectis common stock must be validly tendered as part of this offer. This requirement ensures that the acquisition can proceed without any financial contingency hurdles, streamlining the process for the investment group.

Following the successful closing of the tender offer, Black Pearl plans to facilitate the acquisition of any remaining shares through a short-form merger, which allows them to bypass a stockholder vote. This streamlined approach is anticipated to simplify the process, providing a timely acquisition for both parties involved.

In the ensuing merger, holders of Selectis shares, unless they are held by Black Pearl or stockholders exercising appraisal rights, will be converted into the right to receive the agreed cash price of $5.75 per share. This strategy reflects Black Pearl's commitment to enhancing its operational control within the healthcare market and ensuring quality care delivery across its portfolio.

The regulatory filings related to this tender offer are being managed by Laurel Hill Advisory Group, which is acting as the information agent. Stockholders of Selectis with inquiries or those requiring additional tender offer materials are encouraged to reach out to Laurel Hill via a provided toll-free number or email.

Selectis Health, located in Denver, Colorado, operates numerous healthcare facilities across the South and Southeastern United States, focusing on skilled nursing, assisted living, and independent living services. The company is recognized for its significant contributions to post-acute care services and aims to maintain high standards of resident care while pursuing strategic growth opportunities amid an expanding senior healthcare market.

As Black Pearl Equities moves forward with this tender offer, both firms are navigating a complex landscape of regulatory requirements and market reactions. The investment group’s extensive background in healthcare investments positions them favorably for this acquisition, potentially enhancing their portfolio’s value through Selectis’ established operations and networks.

In a bid to keep stakeholders informed, Selectis will file a Solicitation/Recommendation Statement with the U.S. Securities and Exchange Commission (SEC), emphasizing their board's unanimous recommendation for shareholders to accept the tender offer. This proactive approach illustrates Black Pearl's transparency and commitment to optimal stakeholder engagement throughout the acquisition process.

Conclusion

The commencement of this tender offer marks a pivotal moment for both Black Pearl and Selectis Health, signaling a consolidation effort that could reshape their operational capabilities in the healthcare market. As the deadline approaches, all eyes will be on how stakeholders react and whether the necessary conditions for the tender offer are met. The future of this merger holds potential benefits for both companies and the populations they serve.